These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 31693255)

  • 41. Expression of androgen and estrogen signaling components and stem cell markers to predict cancer progression and cancer-specific survival in patients with metastatic prostate cancer.
    Fujimura T; Takahashi S; Urano T; Takayama K; Sugihara T; Obinata D; Yamada Y; Kumagai J; Kume H; Ouchi Y; Inoue S; Homma Y
    Clin Cancer Res; 2014 Sep; 20(17):4625-35. PubMed ID: 24987058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of human CYP27A1 by estrogens and androgens in HepG2 and prostate cells.
    Tang W; Norlin M; Wikvall K
    Arch Biochem Biophys; 2007 Jun; 462(1):13-20. PubMed ID: 17482558
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Acquisition of androgen independence by human prostate epithelial cells during arsenic-induced malignant transformation.
    Benbrahim-Tallaa L; Webber MM; Waalkes MP
    Environ Health Perspect; 2005 Sep; 113(9):1134-9. PubMed ID: 16140617
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Androgen-Dependent Repression of ERRγ Reprograms Metabolism in Prostate Cancer.
    Audet-Walsh É; Yee T; McGuirk S; Vernier M; Ouellet C; St-Pierre J; Giguère V
    Cancer Res; 2017 Jan; 77(2):378-389. PubMed ID: 27821488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
    Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
    Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Androgen suppresses protein kinase D1 expression through fibroblast growth factor receptor substrate 2 in prostate cancer cells.
    Zhang L; Zhao Z; Xu S; Tandon M; LaValle CR; Deng F; Wang QJ
    Oncotarget; 2017 Feb; 8(8):12800-12811. PubMed ID: 28077787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting the glucocorticoid receptor in breast and prostate cancers.
    Kach J; Conzen SD; Szmulewitz RZ
    Sci Transl Med; 2015 Sep; 7(305):305ps19. PubMed ID: 26378243
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer.
    Sahu B; Laakso M; Ovaska K; Mirtti T; Lundin J; Rannikko A; Sankila A; Turunen JP; Lundin M; Konsti J; Vesterinen T; Nordling S; Kallioniemi O; Hautaniemi S; Jänne OA
    EMBO J; 2011 Sep; 30(19):3962-76. PubMed ID: 21915096
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Androgens downregulate miR-21 expression in breast cancer cells underlining the protective role of androgen receptor.
    Casaburi I; Cesario MG; Donà A; Rizza P; Aquila S; Avena P; Lanzino M; Pellegrino M; Vivacqua A; Tucci P; Morelli C; Andò S; Sisci D
    Oncotarget; 2016 Mar; 7(11):12651-61. PubMed ID: 26862856
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Androgen receptor non-nuclear regulation of prostate cancer cell invasion mediated by Src and matriptase.
    Zarif JC; Lamb LE; Schulz VV; Nollet EA; Miranti CK
    Oncotarget; 2015 Mar; 6(9):6862-76. PubMed ID: 25730905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential regulation of PTEN expression by androgen receptor in prostate and breast cancers.
    Wang Y; Romigh T; He X; Tan MH; Orloff MS; Silverman RH; Heston WD; Eng C
    Oncogene; 2011 Oct; 30(42):4327-38. PubMed ID: 21532617
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Estrogen in Androgen-Induced Prostate Carcinogenesis in NBL Rats.
    Ozten N; Vega K; Liehr J; Huang X; Horton L; Cavalieri EL; Rogan EG; Bosland MC
    Horm Cancer; 2019 Jun; 10(2-3):77-88. PubMed ID: 30877616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgens and bone.
    Vanderschueren D; Vandenput L; Boonen S; Lindberg MK; Bouillon R; Ohlsson C
    Endocr Rev; 2004 Jun; 25(3):389-425. PubMed ID: 15180950
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Androgen-dependent expression of the gastrin-releasing peptide receptor in human prostate tumor xenografts.
    de Visser M; van Weerden WM; de Ridder CM; Reneman S; Melis M; Krenning EP; de Jong M
    J Nucl Med; 2007 Jan; 48(1):88-93. PubMed ID: 17204703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Androgen signaling and its interactions with other signaling pathways in prostate cancer.
    Kaarbø M; Klokk TI; Saatcioglu F
    Bioessays; 2007 Dec; 29(12):1227-38. PubMed ID: 18008377
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anterior prostate epithelial AR inactivation modifies estrogen receptor expression and increases estrogen sensitivity.
    Simanainen U; McNamara K; Gao YR; McPherson S; Desai R; Jimenez M; Handelsman DJ
    Am J Physiol Endocrinol Metab; 2011 Oct; 301(4):E727-35. PubMed ID: 21750267
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of RFG/ELE1alpha/ARA70 in normal and malignant prostatic epithelial cell cultures and lines: regulation by methylation and sex steroids.
    Tekur S; Lau KM; Long J; Burnstein K; Ho SM
    Mol Carcinog; 2001 Jan; 30(1):1-13. PubMed ID: 11255259
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intratumoral conversion of adrenal androgen precursors drives androgen receptor-activated cell growth in prostate cancer more potently than de novo steroidogenesis.
    Kumagai J; Hofland J; Erkens-Schulze S; Dits NF; Steenbergen J; Jenster G; Homma Y; de Jong FH; van Weerden WM
    Prostate; 2013 Nov; 73(15):1636-50. PubMed ID: 23996639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estrogen regulation of the glucuronidation enzyme UGT2B15 in estrogen receptor-positive breast cancer cells.
    Harrington WR; Sengupta S; Katzenellenbogen BS
    Endocrinology; 2006 Aug; 147(8):3843-50. PubMed ID: 16690804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.